electroCore, Inc. (ECOR) Investor Relations Documents

electroCore, Inc. (ECOR) investor relations documents from the company's IR site: 23 press releases. Read in-app with summaries. First-party data.

Investor relations documents — source: company IR site
PublishedTypeDocument
2026-08-06Press releaseelectroCore Announces Second Quarter 2026 Financial Results
2026-07-30Press releaseelectroCore to Announce Second Quarter June 30, 2026, Financial Results on Thursday, August 6, 2026
2026-07-16Press releaseNew Review Examines Anatomical and Methodological Differences Between Auricular and Cervical Vagus Nerve Stimulation
2026-06-17Press releaseelectroCore to Participate in iAccess Alpha Virtual Best Ideas Summer Investment Conference
2026-06-09Press releaseFrontiers in Neuroscience Accepts Review Article Synthesizing Evidence that Cervical nVNS Activates the Vagus Nerve With
2026-06-02Press releaseelectroCore to Present at the Planet MicroCap Las Vegas 2026 Powered by MicroCapClub
2026-05-13Press releaseelectroCore Announces Publication in JAMA Highlighting the Benefits of Adding Quell Electrical Nerve Stimulation to Outp
2026-05-08Press releaseelectroCore to Present at the LD Micro Invitational XVI Conference on May 18, 2026
2026-05-06Press releaseelectroCore Announces First Quarter 2026 Financial Results
2026-04-30Press releaseelectroCore TAC-STIM™ Named National Semifinalist in National Safety Council Work to Zero Challenge
2026-04-29Press releaseelectroCore to Announce First Quarter March 31, 2026, Financial Results on Wednesday, May 6, 2026
2026-04-28Press releaseelectroCore to Present at the Market Movers Investor Summit on May 5, 2026
2026-04-23Press releaseelectroCore Product Line Featured in Documentary Underscoring the Expanding Clinical and Commercial Role of Vagus Nerve
2026-04-08Press releaseelectroCore to Participate in the 25th Annual Needham Virtual Healthcare Conference
2026-04-07Press releaseelectroCore Announces First Patient Enrollment in Investigator-Led Study of gammaCore™ nVNS for PTSD
2026-04-01Press releaseelectroCore Announces Publication in Frontiers in Neuroscience Highlighting Benefits of Non-Invasive Vagus Nerve Stimula
2026-03-31Press releaseelectroCore Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
2026-03-30Press releaseelectroCore Expands Intellectual Property Portfolio
2026-03-19Press releaseelectroCore Announces Full Year 2025 Financial Results and Organizational Changes
2026-03-10Press releaseelectroCore to Participate at the 38th Annual Roth Conference
2026-03-09Press releaseelectroCore to Announce Fourth Quarter and Full Year Ended December 31, 2025, Financial Results on Thursday, March 19, 2
2026-01-21Press releaseAcacia Clinics and Vagus Nerve Society Conduct Study Using electroCore’s gammaCore Sapphire for Adjunctive Treatment of
2026-01-20Press releaseelectroCore Provides Preliminary Full-Year 2025 Business Update; Expects ~26% Revenue Growth to ~$31.8–$32.0 Million

ECOR overview · ECOR earnings · ECOR financials · ECOR KPIs · ECOR ownership · ECOR peers · ECOR filings

Documents published by the company on its investor-relations site; summaries are model-written. Not personalized investment advice.